Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5601results about "Antimycotics" patented technology

Small-molecule antibacterial polypeptide, and preparation method therefor and use thereof

Provided are a small-molecule antibacterial polypeptide, and a preparation method therefor and a use thereof. The antibacterial peptide provided has stronger antibacterial activity than most other derivative polypeptides and antibacterial polypeptides disclosed in existing reports. Multiple strains known for drug resistance are used to carry out bactericidal activity evaluation. The result shows that the antibacterial peptide provided has broad-spectrum antibacterial activity against drug-resistant strains, achieves more comprehensive antibacterial effects, and has a wider range of indications.
Owner:SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD

Iodine compositions

The present invention relates to compositions comprising molecular iodine and a vehicle comprising a semifluorinated alkane. The compositions of the invention may be used to treat or prevent diseases or conditions caused by, or associated with microorganisms.
Owner:DERMALIQ THERAPEUTICS INC

Composite metabiotic microbial inoculum for promoting vaginal micro-ecological balance and application of composite metabiotic microbial inoculum

The invention relates to a composite metabiotic inoculant for promoting vaginal micro-ecological balance and application thereof. Strain in the composite metabiotic inoculant for promoting vaginal micro-ecological balance comprises an inactivated LA88 strain and an inactivated N13 strain. The invention develops a brand-new probiotic intervention strategy for promoting the micro-ecological balance of the vagina, namely, the inactivated lactobacillus acidophilus LA88 strain and the inactivated lactobacillus plantarum N13 strain are compounded to form a brand-new composite metabiotic bacterial agent, and the composite metabiotic bacterial agent has a relatively good proliferation effect on various beneficial bacteria of the vagina, and can be used for preparing the probiotics for promoting the micro-ecological balance of the vagina. The traditional Chinese medicine composition has a strong inhibition effect on various vaginal pathogenic bacteria, and can promote recovery of a healthy microbial community structure.
Owner:CHONGQING BAIYA SANITARY PRODUCTS CO LTD

Broad-spectrum antibacterial peptide, antibacterial agent and application

The invention provides a broad-spectrum antibacterial peptide, an antibacterial agent and application, and belongs to the technical field of biological medicine. The invention provides a broad-spectrum antibacterial peptide. The broad-spectrum antibacterial peptide comprises an amino acid sequence as shown in SEQ ID No. 1. The minimum inhibitory concentration of the antibacterial peptide to gram-positive bacteria, gram-negative bacteria and fungi proves that the antibacterial peptide has obvious antibacterial activity to the gram-positive bacteria, the gram-negative bacteria and the fungi. The invention also verifies the minimum inhibitory concentration of the antibacterial peptide to clinical drug-resistant bacteria. The cytotoxicity of the SL-12 disclosed by the invention is relatively weak, the SL-12 only shows obvious cytotoxicity at 200 [mu] g / ml, and the minimum inhibitory concentration of the SL-12 is 6.25-12.5 [mu] g / ml; the SL-12 has no obvious hemolytic activity when the concentration is 100 [mu] g / ml or lower, and is high in safety.
Owner:KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI

Marine-sourced bacillus velezensis RS3-13, extract and application of marine-sourced bacillus velezensis RS3-13

The invention discloses bacillus velezensis RS3-13 from ocean, an antibacterial active substance produced by the bacillus velezensis RS3-13 and application of the bacillus velezensis RS3-13. The strain RS3-13 is classified and named as bacillus velezensis, and the preservation number of the strain RS3-13 is CGMCC (China General Microbiological Culture Collection Center) No. 27562. According to the invention, bacillus velezensis RS3-13 is subjected to fermentation and macroporous resin separation, two types of antibacterial substances can be obtained, and through TLC-biological self-development and MALDI-TOF / TOF mass spectrometry analysis, one is surfactin, and the other is abrumogen or homologues thereof. The bacterial strain and the two types of antibacterial substances thereof have an inhibition effect on a plurality of microorganisms. The strain RS3-13 is prepared into a microecological preparation, and the microecological preparation is applied to large-scale aquaculture and livestock and poultry breeding, has good adaptability and stress resistance, can stably survive and colonize in a breeding environment, and can inhibit pathogenic bacteria in the breeding environment and change a flora structure.
Owner:QINGDAO BIO-ANTAI BIOTECHNOLOGY CO LTD +3

Lactobacillus plantarum with antibacterial effect and application thereof

The invention relates to the field of microorganisms, and discloses lactobacillus plantarum with an antibacterial effect and application of the lactobacillus plantarum, and the preservation number of the lactobacillus plantarum is CGMCC (China General Microbiological Culture Collection Center) No.33151. The strain provided by the invention has relatively strong cholate resistance, gastric acid resistance, acid production and H2O2 production capabilities, and has a relatively strong bacteriostatic effect on common pathogenic bacteria such as staphylococcus aureus, candida albicans, escherichia coli, salmonella and helicobacter pylori; the compound can inhibit the activity of urease, interfere helicobacter pylori colonization and the like to inhibit helicobacter pylori infection or reduce the symptoms of helicobacter pylori infection and reduce the disease degree of mice with colitis, can be used for preparing microbial preparations, and has the potential of preparing drugs for preventing and / or treating diseases caused by helicobacter pylori infection.
Owner:COFCO NUTRITION AND HEALTH RESEARCH INSTITUTE CO LTD +1

Plant lactobacillus with efficient broad-spectrum bacteriostatic activity

The invention relates to the field of microorganisms, in particular to a plant lactobacillus and application thereof in bacteriostasis. Specifically, the preservation number of the plant lactobacillus LP06 is CGMCC (China General Microbiological Culture Collection Center) No. 28412. The plant lactobacillus LP06 provided by the invention can be used for inhibiting the growth of debaryomyces hansenii, candida tropicalis and penicillium rochei, and also has an inhibiting effect on super bacteria acinetobacter baumannii, pseudomonas aeruginosa, klebsiella, escherichia coli, staphylococcus aureus and listeria monocytogenes. The plant lactobacillus LP06 provided by the invention has broad-spectrum bacteriostatic ability, and bacteriostatic powder prepared from the bacterium can be used as a biological preservative for corrosion prevention of dairy products such as yoghourt, cheese and the like and other foods.
Owner:INNER MONGOLIA YILI IND GROUP CO LTD +2

Micromolecular antibacterial polypeptide, and preparation method therefor and use thereof

The present disclosure relates to the technical field of antibacterial drugs, and specifically relates to a micromolecular antibacterial polypeptide, and a preparation method therefor and the use thereof. The antibacterial peptide provided in the present disclosure has a stronger antibacterial activity compared with most other derived polypeptides and the antibacterial polypeptides disclosed in the existing reports. Bactericidal activity evaluation is carried out by using a plurality of strains known to have drug resistance, and the results show that the antibacterial peptide provided in the present disclosure has broad-spectrum antibacterial activity against drug-resistant strains and more comprehensive antibacterial effects, and allows for wider indications.
Owner:SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD

Preparation and application of cubilose glycopeptide for prevention and adjuvant therapy of gynecological inflammation and gastrointestinal inflammation

The invention relates to the field of cubilose peptides, in particular to preparation and application of cubilose glycopeptides capable of preventing and assisting in treating gynecological inflammation and gastrointestinal inflammation. The invention provides cubilose glycopeptide which comprises cubilose peptide, sialylated O-glycan and sialylated N-glycan, and the cubilose peptide is connected with the sialylated O-glycan and / or the sialylated N-glycan. The cubilose glycopeptide provided by the invention has unique sialylated O-glycans and N-glycans, has unique biological activity and functions and synergistic effect compared with the cubilose glycopeptide without N-glycans or O-glycans and non-sialylated cubilose peptides, and forms and enhances the inhibition effect on pathogens and the antiviral effect; therefore, the compound has unique advantages in the aspect of preventing and treating related problems. The sialic acid binding type cubilose glycopeptide has stronger antibacterial activity, especially has an inhibition effect on pathogens such as candida albicans and helicobacter pylori, and also has an antiviral effect.
Owner:XIAMEN YAN PALACE SEELONG BIOTECHNOLOGY CO LTD

Potato scab biocontrol bacterium bacillus subtilis ZF517 and application thereof

The invention discloses a potato scab biocontrol bacterium bacillus subtilis ZF517 and application of the potato scab biocontrol bacterium bacillus subtilis ZF517. The invention provides a bacillus subtilis strain ZF517, and the preservation number of the bacillus subtilis strain ZF517 is CGMCC (China General Microbiological Culture Collection Center) No.30137. The strain ZF517 is obtained through separation, it is determined that the strain fermentation liquor of the strain ZF517 has the inhibition effect on a streptomyces scabies plate, and it is verified through a radish seedling method and a potting method that the strain ZF517 has the prevention and treatment effect. Bacteriostatic spectrum determination shows that the strain ZF517 has a broad-spectrum bacteriostatic effect, and the bacillus subtilis B.subtilis ZF517 can generate a broad-spectrum antagonistic effect on six pathogenic fungi and has an antagonistic effect on three pathogenic bacteria at the same time; and a basis is provided for development of a potato scab biocontrol agent.
Owner:INSTITUTE OF VEGETABLES & FLOWERS CHINESE ACADEMY OF AGRICULTURAL SCIENCES +1

Bacillus velezensis D34 with biocontrol and water regulation functions and application of bacillus velezensis D34

The invention discloses bacillus velezensis D34 with biocontrol and water transfer functions and application thereof, the preservation number of the bacillus velezensis D34 is CCTCC NO: M 2019457, the preservation unit of the bacillus velezensis D34 is China Center for Type Culture Collection, the preservation address is Wuhan University, Wuhan, Hubei, China, and the preservation date is June 17, 2019. The strain has an inhibition effect on fish pathogen branchiomycosis, has a protection effect on fish pathogenic aeromonas palustris infection, and has a good degradation effect on toxic substances such as ammonia nitrogen and nitrite in aquatic water.
Owner:HUNAN UNIV OF ARTS & SCI

Lactobacillus plantarum and application thereof in preparation of medicine for preventing and / or treating vaginitis

The invention relates to the field of microorganisms, and discloses lactobacillus plantarum and application of the lactobacillus plantarum in preparation of a medicine for preventing and / or treating vaginitis, and the preservation number of the lactobacillus plantarum is CGMCC No.33152. The lactobacillus plantarum provided by the invention has a relatively strong bacteriostatic effect on common vaginal pathogenic bacteria such as Atortoria, staphylococcus aureus, Candida albicans, Escherichia coli and Gardneria, and also can reduce the infection degree of the pathogenic bacteria by inhibiting colonization and reproduction of the pathogenic bacteria; in addition, the proinflammatory factor level in sick vaginitis tissues is reduced, and the anti-inflammatory factor level is improved.
Owner:COFCO NUTRITION AND HEALTH RESEARCH INSTITUTE CO LTD +1

Lactobacillus crispatus LC30 for preventing and treating female genital tract infection and application thereof

The invention relates to lactobacillus crispatus LC30 for preventing and treating female genital tract infection and application of the lactobacillus crispatus LC30. The lactobacillus crispatus LC30 is preserved in the China General Microbiological Culture Collection Center with the preservation number of CGMCC NO.31923. The lactobacillus crispatus LC30 has good hydrogen peroxide production capacity and adhesion capacity, has a strong inhibition effect on main vaginitis pathogenic bacteria, and can be used for preventing and treating female genital tract infection. The composition is effective to nutritional pathogenic bacteria, and can also reduce form transformation and biological membrane formation of the pathogenic bacteria and prevent and treat drug resistance; besides, the fermentation product can reduce the content of pathogenic bacteria metabolites, regulate the secretion of cytokines and achieve the effect of relieving inflammation, so that the fermentation product can be used for preparing products for preventing and treating genital tract pathogenic bacteria infection, preventing and treating vaginitis and / or removing pudendum peculiar smell.
Owner:HEBEI YIRAN BIOLOGICAL TECH CO LTD

Lactobacillus gasseri FMTA1125B with effect of preventing, relieving or treating vaginitis and application of lactobacillus gasseri FMTA1125B

The invention relates to lactobacillus gasseri FMTA1125B with the effect of preventing, relieving or treating vaginitis and application of the lactobacillus gasseri FMTA1125B. The lactobacillus gasseri FMTA1125B is classified and named as lactobacillus gasseri, and the preservation number of the lactobacillus gasseri FMTA1125B is CGMCC No.34292. The lactobacillus gasseri FMTA1125B has the effects of preventing, relieving or treating vaginitis and the application of the lactobacillus gasseri FMTA1125B. The bacterium can produce beneficial components such as lactic acid, gamma-aminobutyric acid and hydrogen peroxide through metabolism so as to regulate the genital tract environment and improve the health degree; and the traditional Chinese medicine composition has relatively good bacteriostasis and sterilization effects on common vaginal pathogenic bacteria such as escherichia coli, staphylococcus aureus, gardnerella vaginalis, candida albicans, neisseria gonorrhoeae and the like. Therefore, the lactobacillus gasseri FMTA1125B strain can be used for preparing a preparation with the effect of improving related genital tract diseases such as vaginitis.
Owner:BEIJING FUMART BIOTECHNOLOGY CO LTD

Lactobacillus crispatus and use thereof

The invention provides lactobacillus crispatus, which is preserved in the general microbiological center of the China Committee for Culture Collection of Microorganisms on February 7, 2023, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No. 26503. The bacillus subtilis can play a relatively strong role in inhibiting pathogenic bacteria such as gardnerella vaginalis, escherichia coli and staphylococcus aureus at the same time, and also has a certain role in inhibiting candida albicans, two-way proteurella and Atortoria vaginalis. Therefore, the lactobacillus crispatus has the potential of maintaining the environment in the vagina to be faintly acid and improving the mucosal immunity and infection resistance of a host, and can be used for preventing and treating vaginal infection and inflammation, and maintaining, improving or recovering the steady state of the environment in the vagina.
Owner:HANGZHOU GRAND BIOLOGIC PHARMA INC

Lactobacillus mucilaginosus for maintaining genital tract health and preventing genital tract infection and application of lactobacillus mucilaginosus

The invention relates to the technical field of microorganisms, and provides lactobacillus mucilaginosus for maintaining genital tract health and preventing genital tract infection and application of lactobacillus mucilaginosus. Fermented mucus lactobacillus for maintaining genital tract health and preventing genital tract infection is named as FMTA1113H and is preserved in China General Microbiological Culture Collection Center (CGMCC) on April 22, 2025, the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number is CGMCC NO.34291. The invention further discloses a preparation method of the fermented mucus lactobacillus for maintaining genital tract health and preventing genital tract infection. According to the technical scheme, the problems that female genital tracts are prone to infection and relapse is prone to occurring after infection in the prior art are solved.
Owner:BEIJING FUMART BIOTECHNOLOGY CO LTD

Antibacterial peptide and application thereof

The invention discloses an antibacterial peptide and application thereof, and belongs to the technical field of biology. The antibacterial peptide with an inhibition effect on various clinically common pathogenic microorganisms is obtained, and the antibacterial peptide comprises gram-negative bacteria such as escherichia coli, klebsiella pneumoniae, pseudomonas aeruginosa, acinetobacter baumannii, vibrio parahaemolyticus, salmonella gallinarum, salmonella typhimurium and enterobacter sakazakii, and gram-positive bacteria. The antibacterial peptide provided by the invention can be used as an antibacterial peptide, such as staphylococcus aureus, listeria monocytogenes and bacillus cereus, and the antibacterial peptide provided by the invention is novel in structure and easy to prepare.
Owner:JIANGNAN UNIV

Antibacterial peptide sequence design framework based on protein language model supervised fine tuning and human feedback reinforcement learning

According to the method, an antibacterial peptide sequence design framework is designed based on protein language model supervised fine tuning and human feedback reinforcement learning, a multiple screening framework is designed, and specifically, an antibacterial peptide design and screening model and a fine tuning mode of the model are developed through an innovative calculation method and a comprehensive analysis process; the method effectively solves the problems of low antibacterial peptide design and screening efficiency, insufficient accuracy, single optimization dimension and the like in the prior art, and an efficient, accurate and flexible new method is provided for research and development of the antibacterial peptide.
Owner:杭州天衍星旅科技有限公司

Special-shaped channel double-structure microneedle device for soft tissue defect repair

The invention discloses a special-shaped channel double-structure microneedle device for soft tissue defect repair. The special-shaped channel double-structure microneedle device comprises an injectable extracellular matrix material, a tree-shaped special-shaped channel microneedle substrate matrix, a conical straight channel microneedle base matrix and a microneedle isolation piece. The needle tip of the substrate matrix is covered with four layers of materials, namely a hemostatic antibacterial layer, a protective layer, a hemostatic ion layer and a biological nutrition layer from inside to outside; the back face of the substrate matrix is covered with a medical-level isolation piece. The heterogenous microneedle substrate matrix sheet is divided into two types: a first type of layered special-shaped channel long microneedles, a bottom end circular bracket and an upper layer tree-shaped layered needle body, and tree-shaped heterogenous channels are arranged in the first type of layered special-shaped channel long microneedles in a penetrating manner; the needle body of the second type of single-layer short microneedle is conical, and a cylindrical straight channel penetrates through the needle body. The special-shaped channel microneedle matrix can effectively penetrate through joint soft tissue, the special-shaped channel microneedle matrix at different angles is attached to the human joint part, the mass of the microneedle can be reduced to the maximum extent, the conveying rate of treatment liquid medicine is increased, and the purpose of rapidly repairing tissue defects is achieved.
Owner:BEIJING UNIV OF CHEM TECH +1

Breast milk-derived limosilactobacillus fermentum MSJK0025 capable of improving intestinal flora condition and use thereof

A breast milk-derived Limosilactobacillus fermentum MSJK0025 capable of improving the intestinal flora condition and the use thereof. The breast milk-derived Limosilactobacillus fermentum MSJK0025 is deposited in the China General Microbiological Culture Collection Center with a deposit number of CGMCC No. 26426. The breast milk-derived Limosilactobacillus fermentum is a new strain isolated from breast milk of healthy puerperae, and is referred to as Limosilactobacillus fermentum MSJK0025. The strain has a good antibiotic sensitivity and stable inheritance of traits, has a good tolerance to acid, bile salts and artificial gastric / intestinal fluid, and has a fast growth rate and good safety. Furthermore, the strain has a strong intestinal colonization capability and can effectively inhibit intestinal pathogenic bacteria such as Escherichia coli, Staphylococcus aureus, Salmonella typhimurium and Candida albicans, but has no inhibitory effects on intestinal probiotics such as Lactobacillus and Bifidobacterium.
Owner:MINSHENG ZHONGKE JIAYI (ZHEJIANG) BIOENGINEERING CO LTD +1

Hydrogel loaded with antibacterial polypeptide as well as preparation method and application of hydrogel

The invention discloses hydrogel loaded with antibacterial polypeptide as well as a preparation method and application of the hydrogel. The preparation method of the hydrogel comprises the steps that antibacterial polypeptide and polyethylene glycol dimethacrylate are subjected to a cross-linking reaction, the hydrogel can be obtained, and the antibacterial polypeptide is obtained through polymerization synthesis of a cationic CBL monomer compound and an HBL monomer compound; the hydrogel has remarkable sterilization and anti-biofilm effects, and in-vitro cytotoxicity shows that the antibacterial polypeptide hydrogel product has no inhibition effect on normal cell growth; when the hydrogel dressing is used as a hydrogel dressing and is combined with novobiocin for use, more than 99% of antibacterial effect is achieved in a diabetes wound infection model and a fungal psoriasis infection model; and when being used as a hydrogel preparation to be combined with fluconazole, the compound has the effect of inhibiting growth of more than 99% of fungi in an animal vaginitis model.
Owner:SUZHOU INFINITE DIMENSIONAL LIFE SCI & TECH CO LTD

Materials architecture for gastric residence systems

The invention provides gastric residence systems with specifically tailored architectures and methods for making such systems. The components of the gastric residence systems can be manufactured by three-dimensional printing or by co-extrusion. The ability to construct precise architectures for the systems provides excellent control over drug release, in vivo stability, and residence time of the systems.
Owner:NORTIVA BIO INC

Micromolecular antibacterial polypeptide, preparation method therefor and use thereof

Provided is an antibacterial peptide having an amino acid sequence X1KRFKKFFX2KLKKWV-NH2, wherein X1 is selected from any one or of amino acids A, C, D, E, F, G, H, K, L, N, M, P, Q, R, S, I, V, W, Y, and T or is absent; and X2 is an amino acid having an aromatic side chain or an amino acid having an alkaline side chain. In view of defects such as poor gastrointestinal fluid stability of antibacterial peptides in the prior art, a brand-new sequence design scheme and preparation method for an antibacterial peptide are provided. By means of a complete or partial D-amino acid substitution or structural derivatization of a peptide sequence, a series of antimicrobial peptides having stronger antibacterial activity and gastrointestinal stability as compared with the prior art are obtained, such that the antibacterial peptides have a wider application range and higher development potential value.
Owner:SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD

Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, and preparation and application thereof

The invention relates to a water-soluble carbon chain substance for adjusting transmembrane transport and fluidity of a cell membrane, and preparation and application thereof. The water-soluble carbon chain substance comprises a carbon chain originally having certain water solubility, and the structure of the water-soluble carbon chain substance comprises at least one or more hydrophobic carbon chain parts and one or more hydrophilic groups or residues; the hydrophobic carbon chain part is coupled with water-soluble molecules to form a high-hydrophilicity compound; the water-soluble carbon chain can be used for preventing and treating infections including viruses, bacteria and fungi; anti-aging; the occurrence of neurodegenerative diseases such as Alzheimer's disease is prevented and reduced; by reducing the non-specific phagocytosis of the nano-drug by cells, the effect of the nano-drug on a target focus is enhanced.
Owner:SUNFOREST (BEIJING) BIOPHARM LTD

Scutellaria baicalensis self-assembled nanoparticles and terbinafine co-loaded nanoparticles as well as preparation method and application of scutellaria baicalensis self-assembled nanoparticles and terbinafine co-loaded nanoparticles

The invention relates to a radix scutellariae self-assembled nanoparticle and terbinafine co-loaded nanoparticle as well as a preparation method and application thereof, and belongs to the technical field of drug nanoparticles. The preparation method comprises the following two steps: preparing scutellaria baicalensis self-assembled nanoparticles, and preparing the scutellaria baicalensis self-assembled nanoparticles and terbinafine co-loaded nanoparticles. The co-loaded nanoparticles are prepared by the preparation method. The invention also discloses application of the co-loaded nanoparticles in treatment of dermatophytosis. The invention has the following advantages: the saturation solubility of baicalin (BCN) and terbinafine (TBF) is increased; the dissolution rate of the terbinafine (TBF) is obviously improved; the antibacterial effect of the TBF is improved; hypha growth, biomass generation and spore germination of three kinds of trichophyton of trichophyton rubrum, trichophyton mentagrophytes and microsporum canis can be inhibited.
Owner:JIANGXI PROVINCIAL PEOPLES HOSPITAL

Bifidobacterium animalis subsp. Lactis B7 as well as composition and application thereof

The invention relates to a bifidobacterium animalis subsp. Lactis B7 as well as a composition and application thereof, and belongs to the technical field of microorganisms, the bifidobacterium animalis subsp. Lactis B7 is preserved in the China Center for Type Culture Collection on April 19, 2024, and the preservation number is CCTCC NO: M2024734. The bifidobacterium animalis subsp. Lactis B7 is named as Bifidobacterium animalis subsp. Lactis B7, the composition is named as Bifidobacterium animalis subsp. Lactis B7, and the composition is named as Bifidobacterium animalis subsp. Lactis B7. The invention also discloses application of the B7 fermentation composition in preparation of medicines for preventing and treating ulcerative colitis, constipation and constipation-type ulcerative colitis. According to the bifidobacterium animalis subsp. Lactis B7, high-yield short-chain fatty acid and indolepropionic acid are achieved, sulforaphane is generated through glucoraphanin, intestinal tract movement is improved, ulcerative colitis or inflammatory bowel disease activity index DAI and weight loss caused by the disease activity index DAI are effectively relieved, mouse colon injury is remarkably relieved, and mucosa layers are protected; the effects of resisting inflammation, inhibiting pathogenic bacteria and improving the intestinal barrier function are achieved.
Owner:SICHUAN GAOFUJI BIOLOGICAL TECH

Antibacterial peptide and application thereof

The invention provides an antibacterial peptide and application thereof, and belongs to the technical field of biological medicine. Based on bioinformatics and an AI technology, a novel broad-spectrum antibacterial peptide is expected to be screened from tick (hard tick shoulder) genomes, and the antibacterial peptide has antibacterial activity on bacteria (including clinical drug-resistant strains) and fungi, does not have obvious cytotoxicity and hemolytic activity, and is an important candidate molecule of anti-infective drugs. In the embodiment of the invention, the minimum inhibitory concentration of the antibacterial peptide on gram-positive bacteria, gram-negative bacteria and fungi is verified, and the antibacterial peptide is proved to have obvious antibacterial activity on the gram-positive bacteria, the gram-negative bacteria and the fungi. The invention also verifies that the minimum inhibitory concentration of the antibacterial peptide to clinical drug-resistant bacteria is equivalent to the minimum inhibitory concentration of the antibacterial peptide to standard strains, and verifies that the antibacterial peptide can be used as a broad-spectrum antibacterial peptide and is named as SL-15.
Owner:KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI

Crystal form of alkynyl pyridine compound and preparation method thereof

The invention discloses a crystal form of an alkynyl pyridine compound and a preparation method of the crystal form, and particularly discloses a crystal form of a compound shown in a formula (I) and a preparation method of the crystal form. # imgabs0 #
Owner:CISEN PHARMA

Heterocycle substituted pyridine derivative antifungal agents

Described herein are heterocycle substituted pyridine derivative antifungal agents and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of fungal diseases and infections.
Owner:BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL